Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01612494 · ClinicalTrials.gov registry record · Phase 1
Hypertonic Saline as Therapy for Pediatric Concussion
A Phase 1 study, sponsored by University of California, San Diego.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT01612494 is a Phase 1 study that has completed, run by University of California, San Diego. The registered enrollment target is 44 participants.
The verdict
NCT01612494, a Phase 1 study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
This single center, blinded, randomized controlled trial evaluated the use of hypertonic saline versus normal saline as therapy for the symptoms of pediatric concussion post head injury. The study hypothesis was that hypertonic saline would improve symptoms of pediatric concussion following head injury as measured on the self-reported Wong Baker Faces Pain Scale as compared to normal saline. The null hypothesis was that there would be no difference in change of reported pain in either group.
Interventions
- OTHER Normal Saline
- DRUG Hypertonic Saline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2010-03 |
| Est. Completion | 2012-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01612494
The ClinicalTrials.gov registry entry for NCT01612494 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Normal Saline is the first listed.
NCT01612494 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01612494 about?
NCT01612494 is a clinical study titled "Hypertonic Saline as Therapy for Pediatric Concussion". This single center, blinded, randomized controlled trial evaluated the use of hypertonic saline versus normal saline as therapy for the symptoms of pediatric concussion post head injury. The study hypothesis was that hypertonic saline would improve symptoms of pediatric concussion following head in...
What is the current status of trial NCT01612494?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2010-03. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01612494?
The interventions under investigation include: Normal Saline (OTHER), Hypertonic Saline (DRUG).
Who is sponsoring clinical trial NCT01612494?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.